{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:23:56Z","timestamp":1768015436621,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 178-kidney transplanted patients (KTxp), the prevalence of hypovitaminosis-D, the presence and novel development of left ventricular hypertrophy(LVH) and the correlations between native Vitamin-D (25OHD) and LVH were evaluated during the 1st year of transplantation (KTx). Clinical and instrumental data were recorded at pre-KTx and at one (T1) and 12 (T12) months after KTx. 25OHD levels were considered sufficient (s25OHD,\u2009\u2265\u200930\u00a0ng\/dL) or insufficient (i25OHD,\u2009&lt;\u200930\u00a0ng\/dL). 25OHD correlated at T1 with parathormone(PTH), and at T12 with 25OHD-T1 and PTH-(T1,T12). At T12, s25OHD (15%) had higher 25OH and alkaline phosphatase (ALP), lower Ca, at T1, and lower PTH-(T1, T12) than i25OH-T12. At T1, KTxp with LVH (LVH-T1pos, 42%) were older and with longer dialysis vintage than LVH-T1neg. At T12, KTxp with LVH (LVH-T12pos, 53%) were older, with higher systolic blood pressure (SBP) at T12 than LVH-T12neg. No relation between 25OHD and LVH were found. Novel LVH was found in 14% of KTxp. They were older, had higher SBP-T12 and lower serum albumin-T12 than the others. LVH-modifications and 25OHD were not correlated. Hypovitaminosis-D is highly prevalent in KTxp. LVH correlates with different risk factors according to the time elapsed from KTx. However, during the 1st year of KTx, no relationship between LVH and 25OHD was observed.<\/jats:p>","DOI":"10.1038\/s41598-020-76261-5","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:03:19Z","timestamp":1604574199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study"],"prefix":"10.1038","volume":"10","author":[{"given":"C.","family":"Alfieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vettoretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Ruzhytska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cresseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Campise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Caldiroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Favi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Binda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"13","key":"76261_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351(13), 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"76261_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","volume":"293","author":"MG Shlipak","year":"2005","unstructured":"Shlipak, M. G. et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293(14), 1737\u20131745 (2005).","journal-title":"JAMA"},{"issue":"9889","key":"76261_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort, R. T. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382(9889), 339\u2013352 (2013).","journal-title":"Lancet"},{"issue":"2","key":"76261_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2215\/CJN.06980615","volume":"11","author":"E Paoletti","year":"2016","unstructured":"Paoletti, E. et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. CJASN 11(2), 271\u2013279 (2016).","journal-title":"CJASN"},{"issue":"8","key":"76261_CR5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/nu11081918","volume":"11","author":"C Alfieri","year":"2019","unstructured":"Alfieri, C. et al. Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients. 11(8), 1918 (2019).","journal-title":"Nutrients."},{"issue":"6","key":"76261_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/ajt.12738","volume":"14","author":"R McGregor","year":"2014","unstructured":"McGregor, R. et al. Vitamin D in renal transplantation\u2014from biological mechanisms to clinical benefits. Am. J. Transplant. 14(6), 1259\u20131270 (2014).","journal-title":"Am. J. Transplant."},{"issue":"1","key":"76261_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40256-013-0047-y","volume":"14","author":"P Messa","year":"2014","unstructured":"Messa, P., Curreri, M., Regalia, A. & Alfieri, C. M. Vitamin D and the cardiovascular system: an overview of the recent literature. Am. J. Cardiovasc. Drugs. 14(1), 1\u201314 (2014).","journal-title":"Am. J. Cardiovasc. Drugs."},{"key":"76261_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1681\/ASN.V92267","volume":"9","author":"RN Foley","year":"1998","unstructured":"Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol. 9, 16-S23 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"76261_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.jrn.2013.07.003","volume":"24","author":"SM Kim","year":"2014","unstructured":"Kim, S. M. et al. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J. Ren. Nutr. 24(1), 20\u201325 (2014).","journal-title":"J. Ren. Nutr."},{"issue":"5","key":"76261_CR10","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.transproceed.2015.04.036","volume":"47","author":"E \u00c7ankaya","year":"2015","unstructured":"\u00c7ankaya, E. et al. Comparison of serum vitamin D levels among patients with chronic kidney disease, patients in dialysis, and renal transplant patients. Transplant Proc. 47(5), 1405\u20131407 (2015).","journal-title":"Transplant Proc."},{"issue":"6","key":"76261_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/nu9060550","volume":"9","author":"P Messa","year":"2017","unstructured":"Messa, P., Regalia, A. & Alfieri, C. Nutritional Vitamin D in renal transplant patients: speculations and reality. Nutrients 9(6), 550 (2017).","journal-title":"Nutrients"},{"issue":"9","key":"76261_CR12","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1093\/ndt\/gfl201","volume":"21","author":"NC Boudville","year":"2006","unstructured":"Boudville, N. C. & Hodsman, A. B. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol. Dial. Transplant. 21(9), 2621\u20132624 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"76261_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1681\/ASN.2012060614","volume":"24","author":"F Bienaim\u00e9","year":"2013","unstructured":"Bienaim\u00e9, F. et al. Vitamin D status and outcomes after renal transplantation. JASN 24(5), 831\u2013841 (2013).","journal-title":"JASN"},{"issue":"2","key":"76261_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5414\/CN109735","volume":"93","author":"Y Battaglia","year":"2020","unstructured":"Battaglia, Y. et al. Vitamin D in kidney transplant recipients. Clin. Nephrol. 93(2), 57\u201364 (2020).","journal-title":"Clin. Nephrol."},{"key":"76261_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4061\/2011\/906832","volume":"1","author":"P Messa","year":"2011","unstructured":"Messa, P., Cafforio, C. & Alfieri, C. Clinical impact of hypercalcemia in kidney transplant. Int. J. Nephrol. 1, 9. https:\/\/doi.org\/10.4061\/2011\/906832 (2011).","journal-title":"Int. J. Nephrol."},{"issue":"6","key":"76261_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/ndt\/13.6.1489","volume":"13","author":"M Ozkahya","year":"1998","unstructured":"Ozkahya, M. et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol. Dial Transplant. 13(6), 1489\u20131493 (1998).","journal-title":"Nephrol. Dial Transplant."},{"issue":"3","key":"76261_CR17","doi-asserted-by":"publisher","first-page":"H585","DOI":"10.1152\/ajpheart.00463.2008","volume":"296","author":"Y Naito","year":"2009","unstructured":"Naito, Y. et al. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am. J. Physiol. Heart Circ. Physiol. 296(3), H585\u2013H593 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"76261_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.mnh.0000247506.79538.3e","volume":"15","author":"JM MacRae","year":"2006","unstructured":"MacRae, J. M. Vascular access and cardiac disease: is there a relationship?. Curr. Opin. Nephrol. Hypertens. 15(6), 577\u2013582 (2006).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"76261_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1748-1716.2008.01862.x","volume":"194","author":"L Paulis","year":"2008","unstructured":"Paulis, L. et al. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of l-arginine and spironolactone. Acta Physiol. 194(1), 45\u201355 (2008).","journal-title":"Acta Physiol."},{"key":"76261_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"AC Sim\u00f5eseSilva","year":"2016","unstructured":"Sim\u00f5eseSilva, A. C. & Teixeira, M. M. ACE inhibition, ACE2 and angiotensin-(1\u00b77) axis in kidney and cardiac inflammation and fibrosis. Pharmacol. Res. 107, 154\u2013162 (2016).","journal-title":"Pharmacol. Res."},{"issue":"10","key":"76261_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.numecd.2013.06.012","volume":"23","author":"G de Simone","year":"2013","unstructured":"de Simone, G., Izzo, R., De Luca, N. & Gerdts, E. Left ventricular geometry in obesity: Is it what we expect?. Nutr. Metab. Cardiovasc. Dis. 23(10), 905\u2013912 (2013).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"Suppl 1","key":"76261_CR22","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1097\/01.ASN.0000093245.78097.CD","volume":"15","author":"G Leoncini","year":"2004","unstructured":"Leoncini, G. et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. JASN 15(Suppl 1), S88-90 (2004).","journal-title":"JASN"},{"issue":"12","key":"76261_CR23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1097\/TP.0b013e3181a76775","volume":"87","author":"E Paoletti","year":"2009","unstructured":"Paoletti, E., Gherzi, M., Amidone, M., Massarino, F. & Cannella, G. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation 87(12), 1864\u20131869 (2009).","journal-title":"Transplantation"},{"issue":"5","key":"76261_CR24","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.transproceed.2016.02.053","volume":"48","author":"K Letachowicz","year":"2016","unstructured":"Letachowicz, K. et al. Prevalence of left ventricular hypertrophy and left ventricular dysfunction in older renal transplant recipients. Transplant Proc. 48(5), 1641\u20131643 (2016).","journal-title":"Transplant Proc."},{"issue":"5","key":"76261_CR25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1681\/ASN.V75728","volume":"7","author":"RN Foley","year":"1996","unstructured":"Foley, R. N. et al. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J. Am. Soc. Nephrol. 7(5), 728\u2013736 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"76261_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/jhh.2011.113","volume":"27","author":"S Masiha","year":"2013","unstructured":"Masiha, S., Sundstr\u00f6m, J. & Lind, L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J. Hum. Hypertens. 27(1), 13\u201317 (2013).","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"76261_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MAJ.0b013e3181aaee91","volume":"338","author":"SE Judd","year":"2009","unstructured":"Judd, S. E. & Tangpricha, V. Vitamin D deficiency and risk for cardiovascular disease. Am. J. Med. Sci. 338(1), 40\u201344 (2009).","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"76261_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson, J. E. et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N. Engl. J. Med. 380(1), 33\u201344 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"76261_CR29","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1001\/jama.2018.17749","volume":"320","author":"T Shoji","year":"2018","unstructured":"Shoji, T. et al. Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism receiving maintenance hemodialysis. JAMA 320(22), 2325 (2018).","journal-title":"JAMA"},{"key":"76261_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2009.374","volume":"77","author":"J-CP Souberbielle","year":"2010","unstructured":"Souberbielle, J.-C.P., Roth, H. & Fouque, D. Parathyroid hormone measurement in CKD. Kidney Int. 77, 93\u2013100 (2010).","journal-title":"Kidney Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76261-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:41:49Z","timestamp":1670366509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76261-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76261"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76261-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19160"}}